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Abstract
The UL13 protein kinase is conserved among many herpesviruses but HSV-2 UL13 specificity is not known. Here, we found that HSV-2 UL13
is a phosphoprotein that autophosphorylates, and that serines within ERK and Cdc2 motifs were important for autophosphorylation but not
for UL13 phosphorylation of exogenous substrates. HSV-2 UL13 phosphorylated a peptide also recognized by ERK and Cdc2. However, mutation
of substrate residues critical for Cdc2 or Erk phosphorylation did not alter HSV-2 UL13 phosphorylation of the peptide, and HSV-2 UL13 did
not phosphorylate standard Cdc2 or Erk peptide substrates. Mutation of prolines surrounding the peptide phosphoacceptor site reduced
phosphorylation by HSV-2 UL13, and a peptide containing serine–proline amid alanines and glycines was phosphorylated. Thus, HSV-2 UL13
does not mimic ERK or Cdc2 substrate recognition and its minimal recognition motif can be serine–proline. This motif's simplicity indicates that
distal sequence or protein structure contributes to HSV-2 UL13 substrate specificity.
© 2007 Elsevier Inc. All rights reserved.Keywords: Kinase; Phosphorylation; Motif; UL13; HSVIntroduction
The Herpesvirus family is divided into alpha, beta, and
gamma-subfamilies. Herpes simplex viruses (HSV) 1 and 2 are
large double-stranded DNA alpha-herpesviruses that are co-
linear and 83% identical at the nucleotide level (Dolan et al.,
1998). HSV virions consist of a host-derived lipid envelope
studded with glycoproteins and an icosahedral capsid surround-
ing the genome. In between the capsid and envelope lies the
tegument, consisting of a layer of viral proteins. One of these
tegument proteins is the serine/threonine protein kinase, UL13
(Coulter et al., 1993; Overton et al., 1992). Tegument proteins
are the first to gain access to the host cell's interior upon in-
fection (Morrison et al., 1998; Roizman and Sears, 1996). Thus,
UL13 can immediately exert its effects on both viral and cellular
targets. UL13 has homologues among the human alpha-, beta-,
and gamma-herpesviruses (Kawaguchi and Kato, 2003) and is
designated UL13 in the alpha-herpesviruses, HSV-1 and HSV-
2, UL97 in the beta-herpesvirus, Human cytomegalovirus
(HCMV), and BGLF4 in the gamma-herpesvirus, Epstein–Barr⁎ Corresponding author. Fax: +1 314 977 8717.
E-mail addresses: canogl@slu.edu (G.L. Cano-Monreal), tavisje@slu.edu
(J.E. Tavis), morrisla@slu.edu (L.A. Morrison).
0042-6822/$ - see front matter © 2007 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2007.11.023virus (EBV) (Chee et al., 1989; McGeoch and Davison, 1986;
Smith and Smith, 1989). HSV-1 and HSV-2 UL13 homologues
have the closest amino acid sequence identity at 85% (Daikoku
et al., 1997). The extensive conservation of UL13 suggests im-
portant roles for UL13 in the HSV replication cycle.
Two functions have been proposed for UL13. First, UL13
activity may promote dissociation of the viral tegument by
phosphorylating other tegument proteins during entry into
newly infected cells (Morrison et al., 1998). Second, UL13
kinase activity may regulate viral gene expression: Growth of
HSV-1 UL13 deletion mutants is attenuated in certain cell lines
(Purves and Roizman, 1992), possibly due to UL13-mediated
effects on expression of the immediate-early protein ICP0 and a
subset of late proteins (Purves et al., 1993; Tanaka et al., 2005).
UL13 contains the eleven classical conserved protein ki-
nase subdomains, including the lysine in subdomain II that
interacts directly with ATP and is required for optimal protein
kinase catalytic activity (Carrera et al., 1993; Hanks et al., 1988;
Iyer et al., 2005; Smith and Smith, 1989). Mutation of this
lysine markedly reduces protein kinase activity (Iyer et al.,
2005; Hanks et al., 1988; He et al., 1997; Kawaguchi et al.,
2003; Kenyon et al., 2001). Phosphotransferase activity of a
kinase and its binding to other proteins are often regulated
by autophosphorylation or phosphorylation by another kinase
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autophosphorylate in vitro (Baek et al., 2002a; Cunningham
et al., 1992; Ogle et al., 1997). One group of investigators found
that the capacity of HCMV UL97 to phosphorylate exogenous
substrates is dependent on autophosphorylation (Michel et al.,
1999) while another found no relationship between HCMV
UL97 autophosphorylation and the phosphorylation of exo-
genous substrates (Baek et al., 2002a). Whether HSV-2 UL13
autophosphorylates and whether autophosphorylation is a
requirement for HSV-1 or HSV-2 UL13 protein kinase activity
on exogenous substrates have not been investigated.
Potential UL13 substrates have been identified by comparing
changes in protein phosphorylation in cells infected with
wild-type and UL13-deficient HSV-1 or by examining UL13
phosphorylation of proteins in vitro. Certain isoforms of ICP22,
ICP0, and the cellular proteins EF-1δ and RNA polII from cells
infected with HSV-1 show slower electrophoretic mobility than
those observed from cells infected with UL13− HSV-1 (Purves
and Roizman, 1992; Ogle et al., 1997; Ng et al., 1998; Long
et al., 1999; Kawaguchi et al., 1998). HSV-2 UL13 also may
recognize EF-1δ as a substrate (Kawaguchi et al., 1999), how-
ever, an HSV-2 UL13-deficient virus has not been generated for
use as a negative control. Phosphorylation of gE, gI and ICP0
by HSV-1 UL13 has also been implied because these proteins
are more heavily labeled with 32P in cells infected with wild-
type virus than UL13-deficient virus (Ogle et al., 1997; Ng
et al., 1998). UL13 itself is labeled in wild-type virus-infected
cells. These observations have been taken to suggest substrate
recognition by UL13, but another kinase activated by UL13
could alternatively have been responsible.
In vitro kinase assays have more definitively identified
proteins that can be substrates of UL13. The HSV tegument
contains UL13, and isolated HSV-1 tegument preparations
release VP22 in a phosphorylation-dependent manner when
incubated with 32P-ATP and Mg2+ (Morrison et al., 1998).
Phosphorylation of released VP22 occurs on serine residue(s).
VP22 in tegument preparations derived from UL13-deficient
virus is less labile in the presence of ATP and Mg2+, implying
that VP22 is a substrate of UL13, but whether VP22 is
phosphorylated in UL13-deficient preparations was not deter-
mined. More direct evidence of UL13 substrate specificity
derives from immunoprecipitated enzyme mixed with isolated
substrate. UL13 immunoprecipitated from HSV-1-infected cells
co-immunoprecipitates with gE and gI. Addition of 32P to these
complexes reveals phosphorylation of gE and gI (Ng et al.,
1998), but not when complexes are derived by anti-gE
immunoprecipitation from UL13-deficient virus-infected cells.
ICP0 and EF-1δ also can be substrates of UL13 because they are
32P-labeled in an in vitro kinase assay which combines
immunoprecipitates of UL13 and ICP0 from infected cell
lysates or EF-1δ from uninfected cells (Ng et al., 1998;
Kawaguchi et al., 1998). Low level phosphorylation of ICP0
also occurs in immunoprecipitates from cells infected with
UL13− virus, but a phosphorylated, slower mobility isoform
typically seen in wild-type virus-infected cells is not generated.
To address the lingering possibility that the wild-type UL13
activates or binds another viral or cellular kinase that thenphosphorylates the apparent UL13 substrate, recombinant
proteins isolated on affinity columns, and enzymatically
inactive UL13-K176M have been used. Kawaguchi et al. thus
confirmed, using baculovirus-expressed UL13 and EF-1δ
fusion proteins, that EF-1δ can be a substrate of HSV-1 UL13
(Kawaguchi et al., 1999). EF-1δ S133A is not phosphorylated
in either uninfected or virus-infected cells (Kawaguchi et al.,
2003). EF-1δ S133 lies within the sequence SPMR correspond-
ing to the Cdc2 phosphorylation recognition motif S/TPX[R/K/
H] (Kawaguchi and Kato, 2003; Kawaguchi et al., 2003; Marin
et al., 1992; Shah et al., 2003). In addition, HSV-1 UL13 and
EBV-BGLF4 can phosphorylate CKII-β at a serine within the
Cdc2 motif, SPVK (Kawaguchi et al., 2003). These data have
led investigators to suggest that HSV-1 UL13 and its homolo-
gues recognize the same motif as the cellular kinase Cdc2
(Kawaguchi and Kato, 2003; Kawaguchi et al., 2003). Recently,
the same in vitro kinase assay was used to demonstrate that
HSV-1 UL13 can directly phosphorylate a recombinant protein
containing a domain of the Us3 protein kinase Kato et al.,
2006).
UL13 and cellular kinases mediate phosphorylation of the
HSV tegument protein VP22 in co-transfected cells; however,
the pattern of VP22 phosphorylation differs between HSV-1 and
HSV-2 (Elliott et al., 1999; Geiss et al., 2004). HSV-2 UL13-
dependent phosphorylation sites on VP22 have been mapped to
serines 28 and 34. Only one of these serines is conserved in
HSV-1 VP22, and phosphorylation induced by HSV-1 UL13 at
this site has not been demonstrated. HSV-2 VP22 serines 28 and
34 lie within the amino acid sequence PVS28PADPES34PRD
containing overlapping ERK and Cdc2 recognition motifs
(Geiss et al., 2004). The ERK recognition motif has been
defined as PXS/TP (Alvarez et al., 1991; Clark-Lewis et al.,
1991; Gonzalez et al., 1991), and Cdc2 can recognize broader
versions of its consensus motif including S/TPXD or S/TPXX
[R/K/H/D] (Nigg, 1991; Shah et al., 2003; Srinivasan et al.,
1995). HSV-2 UL13-mediated phosphorylation of VP22 at
serines within these motifs suggests two possibilities: HSV-2
UL13 may recognize a broader version of the Cdc2 motif
putatively recognized by HSV-1 UL13, or HSV-2 UL13 may
recognize a motif different than that predicted for HSV-1 UL13,
either the ERK motif or a novel motif. Defining the HSV-2
UL13 recognition motif would permit identification of sites at
which known UL13 protein substrates are phosphorylated and
would aid identification of novel UL13 substrates. Therefore,
we investigated whether HSV-2 UL13 mimics ERK or Cdc2
substrate recognition by using peptide substrates in in vitro
kinase assays.
Results
HSV-2 UL13 is a phosphoprotein
Phosphorylation of UL13 occurs in HSV-1-infected cells
(Overton et al., 1992; Ng et al., 1998). To determine whether
HSV-2 UL13 is phosphorylated during infection, Vero cells
were infected with HSV-2 333-UL13-HA (a virus expressing 3′
HA-tagged UL13) and incubated with 32P-orthophosphate from
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pitated with the anti-HA monoclonal antibody 3F10. The
complexes were resolved by SDS–PAGE and subjected to
western blot and phosphorimager analysis (Fig. 1). Western blot
with 3F10 revealed the presence of UL13-HA in the
immunoprecipitate from cells infected with 333-UL13-HA
and in an in vitro translated sample of UL13-HA (Fig. 1A, lanes
2 and 3). Slower mobility isoforms of UL13 were apparent in
the immunoprecipitate from 333-UL13-HA infected cells
(Fig. 1A, lane 2). Phosphorimager analysis of the western blot
revealed a 32P-labeled band in the 333-UL13-HA sample that
corresponded to the slower isoforms of UL13-HA on the
western blot (Fig. 1B, lane 2) indicating that HSV-2 UL13 is
phosphorylated in infected cells.
HSV-2 UL13 autophosphorylates
HSV-1 UL13 can autophosphorylate in vitro (Cunningham
et al., 1992; Ogle et al., 1997), but HSV-2 UL13 autopho-
sphorylation has not been demonstrated. To determine whether
HSV-2 UL13 autophosphorylates, UL13-HA and the enzyma-
tically inactive UL13-K176A-HA were expressed by coupled
in vitro transcription/translation, immunoprecipitated, washed
extensively and subjected to an in vitro kinase assay. The
products were resolved by SDS–PAGE and detected by both
autoradiography and by western blot using an anti-HA anti-
body (Fig. 2). Autoradiography revealed a band labeled with
32P (Fig. 2B, lane 1) corresponding with the position on the
western blot of a small proportion of UL13-HA that migrated
with slightly reduced mobility (asterisk, Fig. 2A, lane 1). InFig. 1. HSV-2 UL13 is a phosphoprotein. Vero cells were uninfected or infected
with the HSV-2 recombinant 333-UL13-HA at an MOI of 20 then labeled with
32P-orthophosphate from 4 to 10 h post-infection. Lysates were immunopreci-
pitated with an HA-specific mAb, resolved by SDS–PAGE and subjected to
(A) western blot using the 3F10 mAb and (B) phosphorimager analysis. An
UL13-HA in vitro translation product served as a control for detection by
western but was not subjected to 32P labeling. Asterisks denote the position of
UL13-HA on the western blot and phosphorimage.comparison, K176A-HA migrated as a tighter band (Fig. 2A,
lane 2) and produced only a faint 32P-labeled band on
autoradiography (Fig. 2B, lane 2), possibly from background
phosphorylation of K176A-HA by a kinase in the translation
lysate. Phosphorimager analysis indicated that the 32P signal
from UL13-HA was 38-fold greater than from K176A-HA.
32P-labeled product could be re-immunoprecipitated from the
UL13-HA reaction with the anti-HA antibody but not from
the K176A-HA reaction (data not shown), confirming that
the phosphorylated band in lane 3 is HA-tagged UL13.
These results indicate that HSV-2 UL13 can autophosphorylate
in vitro.
Serines within ERK and Cdc2 recognition motifs are important
for HSV-2 UL13 autophosphorylation but are not essential for
phosphorylation of exogenous substrates
Our previous data suggested that HSV-2 UL13 could
phosphorylate a serine residue within Cdc2 and/or ERK
recognition motifs (Geiss et al., 2004) and that HSV-2 UL13
could be a substrate for itself. Therefore, we analyzed the
HSV-2 UL13 sequence and found that serine 118 lies in the
phosphoacceptor sites of overlapping ERK and Cdc2 motifs
(Fig. 3A). To investigate whether HSV-2 UL13 can autopho-
sphorylate S118, we made an alanine mutation at S118,
translated UL13 and UL13-S118A in vitro and performed an
in vitro kinase assay. The S118A mutation reduced autopho-
sphorylation of UL13 by approximately 40% (Fig. 3B). A serine
at position 121 (S121) also lies within the Cdc2 phosphoryla-
tion motif but not at the phosphoacceptor site. To determine
whether S121 contributes to HSV-2 UL13 autophosphorylation,
an alanine mutation was made at S121 within pSG5-UL13-HA
(UL13-S121A). The S121A mutation decreased UL13 autopho-
sphorylation by approximately 80% (Fig. 3B). Interestingly, an
S118A/S121A double mutant did not decrease UL13 auto-
phosphorylation further than the S121A single mutant
(Fig. 3B). Together, these data indicate that S118 and S121
are phosphoacceptor sites or that they play another important
role in UL13 autophosphorylation.
Autophosphorylation often regulates the capacity of a kinase
to phosphorylate exogenous substrates. Therefore, we examined
the effect of the serine-to-alanine mutations on the capacity of
UL13 to phosphorylate an exogenous substrate, myelin basic
protein (MBP). UL13-S118A phosphorylated MBP to wild-
type levels and UL13-S121A and UL13-S118A/S121A were
able to phosphorylate MBP to 25% of wild-type levels. There-
fore, autophosphorylation of HSV-2 UL13 is not essential for
its activity on exogenous substrates (Fig. 3C).
HSV-2 UL13 can phosphorylate a HSV-2 UL13 peptide
The mutational analysis of HSV-2 UL13 suggested that
HSV-2 UL13 phosphorylates a serine within an ERK or Cdc2
recognition motif. To test whether HSV-2 UL13 could phos-
phorylate a peptide substrate containing these motifs, we gen-
erated a peptide based on the wild-type HSV-2 UL13 sequence,
APPSPPSHILGGRRR (amino acids 116–124 in bold),
Fig. 3. The effect of serine-to-alanine mutations on HSV-2 UL13 autophosphorylation and phosphorylation of exogenous substrates. (A) Overlapping ERK and Cdc2
phosphorylation recognition motifs of HSV-2 UL13. S118 (bold) is the phosphoacceptor for both motifs. HA-tagged UL13 and UL13 mutants were subjected to in
vitro kinase assays (B) in the absence of an exogenous substrate (⁎P≤ 0.03 to ⁎⁎⁎P≤0.001 relative to WT UL13) or (C) in which the exogenous substrate myelin
basic protein was added (⁎⁎P≤0.01 relative to WT UL13; see Materials and methods for statistical analyses). Data are the mean±SD from three experiments.
Representative phosphorimages are shown for experiments denoted in panel B (D and E) and panel C (F).
Fig. 2. HSV-2 UL13 autophosphorylates. UL13-HA, K176A-HA and empty vector pSG5 (Mock) were translated in vitro, isolated by immunoprecipitation and
subjected to an in vitro kinase assay. Proteins were resolved by SDS–PAGE and (A) HA-tagged UL13 and K176Awere detected by western blot using HA-specific
mAb 3F-10 and inset and (B) 32P-labeled protein was detected by autoradiography of the western blot and inset. Asterisk denotes slower mobility isoform of UL13.
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Fig. 5. Serine 118 and serine 121 can be phosphoacceptors for HSV-2 UL13.
UL13-HA was expressed by in vitro transcription/translation, immunoprecipi-
tated and subjected to an in vitro kinase assay for 30 min using serine-to-alanine
mutant peptides and the UL13-WT peptide as substrates at the indicated con-
centrations. Values were normalized to UL13 phosphorylation of the UL13-WT
peptide at 2 mM. The data are the average of three experiments±SD.
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translated UL13-HA and K176A-HAwere immunoprecipitated
and subjected to an in vitro kinase assay to which increasing
concentrations of the UL13-WT peptide were added (Fig. 4A).
Phosphorylation of UL13-WT peptide by UL13 was readily
detectable after 30 min at 0.5 mM and became saturated at
approximately 3.5 mM. A time course experiment showed an
increase in phosphorylation of the UL13-WT peptide over a
span of 180 min (Fig. 4B) ensuring that the in vitro kinase assay
carried out at 30 min is within the linear range. Therefore,
the UL13-WT peptide can serve as a substrate for HSV-2 UL13
in vitro.
HSV-2 UL13 can phosphorylate S118 and S121 in the
UL13-WT peptide
The UL13-WT peptide contains S118 at the phosphoaccep-
tor position for both ERK and Cdc2, and S121 within the Cdc2
recognition motif but not at the phosphoacceptor site. Because
alanine mutations at both S118 and S121 within HSV-2 UL13
decreased autophosphorylation, we synthesized peptides with
alanine substitutions at S118 and S121 in the context of the
UL13-WT peptide to determine which serine was the phos-
phoacceptor. S118A decreased phosphorylation of the UL13
peptide by approximately 60%, S121A decreased phosphoryla-
tion by approximately 80%, and the double mutant ablated
phosphorylation of the peptide (Fig. 5). Therefore, HSV-2Fig. 4. HSV-2 UL13 can phosphorylate an HSV-2 UL13 peptide. UL13-HA and
K176A-HA were translated in vitro, immunoprecipitated and subjected to an
in vitro kinase assay using the UL13-WT peptide as a substrate (A) at increasing
concentrations at a single time point of 30 min or (B) over time at a concen-
tration of 1 mM. Data are the mean±SD from three experiments.UL13 can phosphorylate S118 and S121 in the UL13 peptide.
Preliminary mass spectrometry data are consistent with the
possibility that both residues are phosphorylated simultaneously
on the same molecule (not shown).
HSV-2 UL13 does not phosphorylate standard ERK and Cdc2
peptide substrates
To determine whether HSV-2 UL13 does not mimic ERK or
Cdc2 substrate recognition, standard ERK and Cdc2 peptide
substrates were tested for phosphorylation by HSV-2 UL13. A
myelin basic protein (MBP) peptide corresponding to residues
95–98 of MBP contains the ERK recognition motif PRTP and is
used as an ERK substrate in in vitro kinase assays (Clark-Lewis
et al., 1991). A CKII-β peptide is commonly used as a Cdc2
substrate in in vitro kinase assays because it contains the Cdc2
recognition sequence SPVK corresponding to residues 209–
212 of CKII-β (Litchfield et al., 1995). In addition, this
sequence within CKII-β can be recognized by HSV-1 UL13
and EBV BGLF4 (Kawaguchi et al., 2003). The MBP and
CKII-β peptides were phosphorylated by ERK and Cdc2,
respectively (Figs. 6A and B). However, phosphorylation of
the MBP peptide by HSV-2 UL13 was barely detectable, and
32P-incorporation into the CKII-β peptide was 90% less than
UL13-WT (Fig. 6C). Thus, peptide substrates containing op-
timal ERK or Cdc2 recognition motifs are not readily phos-
phorylated by HSV-2 UL13. Taken together, these data indicate
that HSV-2 UL13 does not mimic either ERK or Cdc2 substrate
recognition.
HSV-2 UL13 is sensitive to mutations in prolines surrounding
the phosphoacceptor
To identify residues crucial for HSV-2 UL13 substrate
specificity, peptides were synthesized containing substitutions
in the context of the UL13-WT peptide (Table 1). A proline at
position +1 (P119) relative to the phosphoacceptor S118 is
crucial for ERK and Cdc2 substrate recognition; hence peptide
P119A was synthesized. A charged residue at position +4 is
important for Cdc2 substrate recognition, so peptide H122A
Fig. 6. HSV-2 UL13 does not phosphorylate ERK or Cdc2 peptide substrates.
(A) Phosphorylation of MBP and UL13-WT peptides by ERK. (B) Phos-
phorylation of CKII-β and UL13-WT peptides by Cdc2. (C) UL13-HA was
translated in vitro, immunoprecipitated and subjected to an in vitro kinase assay
for 30 min using standard ERK and Cdc2 substrate peptides. Values were
normalized to UL13 phosphorylation of the UL13-WT peptide at 2 mM. The
data are the average of three experiments±SD.
Fig. 7. HSV-2 UL13 is sensitive to proline mutations. (A) The UL13-WT
peptide and mutant peptides were used at 1 mM as substrates for ERK in an in
vitro kinase assay. Values are the average of 2 experiments ± the range. (B) The
UL13-WT peptide or mutant peptides were used at 1 mM as substrates for Cdc2
in an in vitro kinase assay. Values are the average of 2 experiments± the range.
(C) UL13-HA was expressed by in vitro transcription/translation, immunopre-
cipitated and subjected to an in vitro kinase assay for 30 min using the UL13-
WT peptide or UL13-WTmutant peptides as substrates. Values were normalized
to UL13 phosphorylation of the UL13-WT peptide at 2 mM. The data are the
average of three experiments±SD.
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in the Cdc2 recognition motif. These peptides were used as
substrates for HSV-2 UL13, ERK and Cdc2 in in vitro kinase
assays. As expected, P119A ablated recognition of the UL13
peptide by ERK and Cdc2, and H122A greatly decreased Cdc2
recognition of the UL13 peptide (Figs. 7A and B). In contrast,









UL13-WT peptide and UL13 mutant peptides used in in vitro kinase assays. The
putative phosphoacceptors are in bold.type levels (Fig. 7C). Surprisingly, ERK phosphorylation of the
H122A peptide was also reduced (Fig. 7A), even though a
histidine at position +4 is not known to be necessary for ERK
recognition (Songyang et al., 1996). To determine whether
amino acids in other positions are important for substrate
recognition by HSV-2 UL13, alanine substitutions were made at
prolines across the UL13-WT peptide. Alanine substitutions at
prolines 116, 117, and 120 decreased phosphorylation by HSV-
2 UL13 more than 50%. A decrease in phosphorylation by ERK
and Cdc2 was also observed when alanine mutations were made
at prolines 116, 117 and 120. These results indicate that UL13
7G.L. Cano-Monreal et al. / Virology 374 (2008) 1–10substrate recognition is sensitive to alanine substitutions at
multiple residues flanking the phosphoacceptor sites and that
proline residues in the vicinity of the phosphoacceptor site are
important for HSV-2 UL13 phosphorylation.
HSV-2 UL13 can phosphorylate a simple serine and proline
motif
Phosphorylation of the UL13-WT peptide by UL13 was
reduced more than 50% only when proline-to-alanine substitu-
tions were made one or two residues before a serine and to a
lesser extent after a serine (Fig. 7C). Thus, the peptide data
indicate that HSV-2 UL13 may recognize a motif consisting of a
serine adjacent to proline residues (Fig. 7C). To test this
prediction, we synthesized peptides containing a serine
preceded or followed by a proline. The SP or PS sequences
were in this case flanked with alternating alanines and glycines
to determine the minimal recognition motif for HSV-2 UL13.
The PS and SP peptides were used as substrates for HSV-2
UL13 in an in vitro kinase assay and phosphorylation was
compared to that of the UL13-WT peptide. HSV-2 UL13 phos-
phorylated the peptide containing a serine followed by a pro-
line and to a much lesser extent a proline followed by a serine
(Fig. 8). Therefore, SP flanked by alanine and glycine residues
can serve as a minimal phosphorylation recognition motif for
HSV-2 UL13.
Discussion
We have (1) demonstrated that HSV-2 UL13 is phos-
phorylated in infected cells, (2) demonstrated that HSV-2
UL13 can autophosphorylate, (3) identified potential phos-
phoacceptor sites for HSV-2 UL13 autophosphorylation, (4)
demonstrated that autophosphorylation is not required for
HSV-2 UL13 to phosphorylate exogenous substrates, (5)
demonstrated that the HSV-2 UL13 recognition motif differs
from that of ERK and Cdc2 and (6) determined that SPFig. 8. HSV-2 UL13 can phosphorylate a peptide containing a serine followed
by a proline. UL13-HA was translated in vitro, immunoprecipitated and
subjected to an in vitro kinase assay for 30 min using the UL13-WT, PS or SP
peptides as a substrate. Values were normalized to UL13 phosphorylation of the
UL13-WT peptide at 2 mM. The data are the average of three experiments±SD.flanked by alanines and glycines can be a minimal recognition
motif for HSV-2 UL13.
The inactivity of UL13-K176A strongly suggests that lysine
176 in subdomain II is required for catalytic activity and
autophosphorylation, as has been seen when the lysine in
subdomain II is mutated in UL13 homologues (He et al., 1997;
Kenyon et al., 2001). A significant decrease in HSV-2 UL13
autophosphorylation occurred when alanine mutations were
made at either S118 or S121. This result suggests that S118 and
S121 are sites of HSV-2 UL13 autophosphorylation or form
important components of the recognition motif. We cannot rule
out the possibility that these mutations altered UL13 folding,
resulting in loss of activity or decreased phosphorylation at
another phosphoacceptor site, or reducing the affinity of UL13
for its substrate. However, S118 and S121 do not lie within
catalytic subdomains of Ser/Thr protein kinases but instead are
found 39 and 36 residues, respectively, upstream of subdomain
I. In addition, neither mutation observably altered protein
accumulation or mobility in SDS–PAGE. Analysis of HSV-2
UL13 by mass spectrometry will be needed to definitively
demonstrate autophosphorylation at both S118 and S121.
Additional minor autophosphorylation sites may exist because
autophosphorylation is not completely ablated in the double
S118A/S121A mutant. However, because we were not able to
employ a purified recombinant enzyme preparation, we cannot
completely exclude the possibility that a contaminating cellular
kinase phosphorylates HSV-2 UL13 at a low level.
Whereas both the S118A and S121A mutations significantly
reduced autophosphorylation, only the S121A mutation sig-
nificantly reduced the capacity of HSV-2 UL13 to phosphory-
late exogenous substrates. This result is consistent with the
possibility that autophosphorylation at S121 augments HSV-2
UL13 protein kinase activity, but it is also possible that the
S121A mutation altered UL13 conformation and consequently
its substrate binding or kinase activity. Nevertheless, phosphor-
ylation of exogenous substrates occurred even with the S121A
mutation. Thus, HSV-2 UL13 resembles HCMV UL97 because
both autophosphorylate, but their capacities to phosphorylate
exogenous substrates are not strictly dependent on autopho-
sphorylation (Baek et al., 2002a).
We originally hypothesized that HSV-2 UL13 recognizes
ERK or Cdc2 motifs, or both motifs, based on data showing that
(1) HSV-2 UL13 mediates phosphorylation of HSV-2 VP22 at
serines within overlapping ERK and Cdc2 recognition motifs
(Geiss et al., 2004); (2) HSV-2 UL13 autophosphorylates at a
serine within overlapping ERK and Cdc2 motifs; and (3) HSV-1
UL13 and the EBV UL13 homologue, BGLF4, recognize a
sequence within EF-1δ and CKII-β consistent with the Cdc2
recognition motif (Kawaguchi and Kato, 2003; Kawaguchi
et al., 2003). Therefore, we used synthetic peptides to address
this hypothesis. Our data showed that HSV-2 UL13 does not
mimic ERK or Cdc2 substrate recognition because substitutions
within a peptide in the UL13 autophosphorylation sequence at
residues critical for recognition by ERK and/or Cdc2 ablated
phosphorylation by ERK and Cdc2 but did not markedly affect
phosphorylation by HSV-2 UL13. Conversely, HSV-2 UL13
phosphorylation of conventional ERK and Cdc2 peptide
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UL13-WT peptide. The Cdc2 peptide substrate CKII-β contains
the SPVK sequence recognized by Cdc2, HSV-1 UL13 and
EBV BGLF4. However, not all UL13 homologues utilize the
Cdc2 motif. The HCMV UL13 homologue UL97, for example,
is not proline-dependent (Baek et al., 2002b). Our data
demonstrate that HSV-2 UL13 recognizes a novel phosphory-
lation motif apparently not shared with some other UL13
homologues, although direct comparison of HSV-2 UL13 with
UL13 homologues will be needed to explicitly demonstrate that
their substrate recognition motifs differ.
The capacity of HSV-2 UL13 to phosphorylate the UL13-
WT peptide except when alanine substitutions are made at
prolines adjacent to serines suggests that a serine flanked
by prolines can serve as an HSV-2 UL13 recognition motif, and
the data in Fig. 8 are consistent with this prediction. While we
cannot discount a potential influence of the glycines and
alanines on recognition of the SP or PS peptides, HSV-2 UL13
phosphorylation of the SP peptide was more readily detected
than that of the PS peptide despite being surrounded by the
same glycine–alanine background. The SP motif appears
simplistic based on primary amino acid sequence, but the
secondary structure of a protein or peptide can be constrained by
this short sequence because a single proline residue is often
associated with a beta-turn (Hall et al., 1991; Rose et al., 1985).
Sequence alignments of HSV-2 UL13 with other known
proline-directed kinases, however, did not show homology at
the site thought to form a pocket for a serine phosphoacceptor
followed by a proline (not shown).
Although the widely accepted optimal ERK consensus
motif is PXS/TP, it had been suggested that the minimal motif
for ERK is S/TP and that the proline at the −2 position in the
optimal recognition motif is strongly preferred but not required
(Haycock et al., 1992). This hypothesis had been tested using
a degenerate peptide library, which demonstrated that ERK
could phosphorylate SP-containing peptides with hydrophobic
amino acids at the −2 position, although proline was preferred
(Songyang et al., 1996). In the present study, we found that
ERK also can phosphorylate SP within a uniform, relatively
neutral glycine–alanine background. Therefore, although
HSV-2 UL13 does not recognize the optimal ERK recognition
motif, it does recognize the same minimal SP motif identified
for ERK.
SP can be found in a vast number of proteins, but HSV-2
UL13 does not promiscuously phosphorylate proteins in in-
fected cells. Therefore, additional residues or structural features
must contribute to HSV-2 UL13 substrate specificity. HSV-2
UL13 substrate recognition may be increased by additional
prolines near the phosphoacceptor site. This is suggested
because HSV-2 UL13 efficiently phosphorylates UL13 peptides
except when substitutions are made at serines or prolines at
residues 116, 117 and 120 in the UL13 sequence. Other residues
may hinder UL13 recognition, as has been previously shown for
some kinases (Pinna et al., 1984). For example, the CKII-β
peptide contains an SP, but it is not phosphorylated by HSV-2
UL13. Therefore the amino acid context surrounding the phos-
phoacceptor site can influence UL13 substrate recognition. Inaddition, amino acid sequences outside of the immediate
recognition motif may convey a large portion of UL13 substrate
specificity, presumably sequences which influence binding of
the substrate to UL13. Predicting UL13 substrates will therefore
require a full understanding of this binding specificity in
addition to the recognition motif.
Materials and methods
Plasmids
UL13 mutant constructs were derived from pSG5-UL13
which contains the UL13 gene of HSV-2 strain 186 downstream
of the SV40 early promoter in pSG5 (Stratagene). pSG5-UL13-
K176A contains an alanine mutation at lysine 176, resulting in
an enzymatically inactive UL13. pSG5-UL13-S118A, pSG5-
UL13-S121A and pSG5-UL13-S118AS121A were constructed
in the pSG5-UL13 background. All plasmids contain an in-
fluenza hemagglutinin (HA) tag fused to the carboxy terminus
of UL13.
Transcription/Translation assay
The TNT T7 coupled reticulocyte lysate system (Promega)
was used for in vitro transcription/translation according to
manufacturer's recommendations. For experiments examining
autophosphorylation and protein kinase activity of UL13-
mutants, 20 μCi of [35S]methionine (Perkin Elmer; N1000 Ci/
mmol) was added during translation.
Peptides and peptide synthesis
UL13, SP and PS peptides were synthesized by standard F-
moc chemistry using a multiple peptide synthesizer (Symph-
ony/Multiplex; Protein Technologies). Following synthesis,
peptides were HPLC purified and their purity was assessed by
mass spectrometry. The WT-UL13 peptide and UL13 residue
substitution peptides contain HSV-2 UL13 wild-type sequence,
amino acids 116–124. The alanine upstream of position 116 and
the glycines downstream of the WT sequence are arbitrary.
Arginines were placed at the end of all peptide sequences to
facilitate binding to P81 phosphocellulose.
Immunoprecipitation
Translation products were precleared twice for 30 min each
with protein A/G agarose beads (Oncogene Research) at 4 °C in
immunoprecipitation buffer (50 mM Tris–HCl [pH 8.0],
150 mM NaCl, 1% NP-40) supplemented with 40 mM sodium
fluoride, 1 mM sodium orthovanadate, 10 mM β-glyceropho-
sphate, 2 μg/ml aprotinin, 3 μg/ml leupeptin and 1 mM
phenylmethylsulfonyl fluoride then incubated with protein A/G
agarose beads complexed with anti-HA antibody (3F10; Roche
Diagnostics) for 3 h at 4 °C in immunoprecipitation buffer. The
immunoprecipitates were washed three times with cold
immunoprecipitation buffer and then used directly in in vitro
kinase assays.
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Proteins were resolved by SDS–PAGE and transferred to
polyvinylidene difluoride membranes (Millipore). Target pro-
teins were bound by the 3F-10 antibody and detected with an
alkaline phosphatase-conjugated secondary antibody and NBT/
BCIP (Promega).
32P-labeling of infected cells and detection of labeled products
Vero cells in 25-cm2 flasks were infected with 333-UL13-
HA at an MOI of 20 or left uninfected. From 3 h to 4 h post-
infection cells were incubated in phosphate-free medium then
labeled with 200 μCi of 32P-orthophosphate (Perkin Elmer) for
6 h. Following the labeling period, cells were washed with 1×
PBS and lysed in the immunoprecipitation (IP) buffer described
above. Radiolabeled lysates were precleared and immunopre-
cipitated with protein A/G agarose beads complexed with anti-
HA antibody, 3F10, as described above. Immunoprecipitated
proteins were separated by SDS–PAGE and subjected to
western blot and phosphorimager analysis.
In vitro kinase assays
Kinase assays were performed with UL13 immobilized on
protein A/G beads and peptide substrates added at indicated
concentrations in a total volume of 25 μl kinase assay buffer
(25 mM Tris–HCl [pH7.5], 20 μM EGTA) supplemented with
Magnesium/ATP cocktail (Upstate) and 10 μCi [γ-32P]ATP
(Perkin Elmer; 3000 Ci/mmol) at 30 °C for 30 min. The
reaction was then centrifuged to separate the enzyme bound to
beads from substrate in the supernatant. Supernatants were
spotted onto P81 phosphocellulose papers (Whatman), and the
filters were washed five times for 5 min with 0.75% phos-
phoric acid then once with acetone. Filters were transferred to
vials containing scintillation cocktail and retained radioactivity
was determined using a beta counter (Ludlum model 2). All
assays were done in triplicate unless otherwise noted. In all
experiments (except for Fig. 4), values for phosphorylation of
the substrates by K176A were designated as background
and subtracted from values for UL13 phosphorylation of
substrates.
In vitro autophosphorylation assay
35S-labeled UL13 or mutants obtained by in vitro translation
were immunoprecipitated and subjected to the in vitro kinase
assay in the absence of an exogenous substrate. Products were
resolved by SDS–PAGE and phosphorimager analysis was
used to quantitate the total amount of enzyme (35S-labeled)
(obtained before the addition of 32P) and autophosphorylated
enzyme (32P-labeled). The phosphorimager intensity value of
32P-labeled enzyme was divided by the value of 35S-labeled
enzyme to normalize for translation efficiency. Values for the
UL13 mutants were normalized to the wild-type UL13 value set
to 1. In samples containing both 32P and 35S, the 35S signal was
shielded by a sheet of exposed X-ray film between the blot andphosphorimager plate (Cao et al., 2005; Tavis et al., 1998).
Statistics were obtained by a one-way ANOVA followed by a
Bonferroni post hoc and a P-value of 0.05.
MBP in vitro kinase assay
Myelin basic protein (MBP) was used as an exogenous
protein substrate in the in vitro kinase assay described above.
17.9 μM MBP (Upstate) was added to the UL13 immunopre-
cipitates in kinase assay buffer. Recombinant activated ERK 1
(Upstate) was used as a positive control for assays involving
MBP. Values for phosphorylation of a substrate by the inactive
K176A mutant were designated as background and were sub-
tracted from all other values. To compare phosphorylation of
MBP by UL13 and UL13 mutants, the samples were normalized
for translation efficiency as described above.
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